chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: numbness and tingling; low back pain; prickling sensation; cervogenic headaches; muscle pain; nerve pain; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (numbness and tingling), NEURALGIA (nerve pain), BACK PAIN (low back pain), PAIN (prickling sensation) and MYALGIA (muscle pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Cervical discectomy (Disc replacement in cervical small annular tear in C4).   On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced NEURALGIA (nerve pain) and MYALGIA (muscle pain). On an unknown date, the patient experienced PARAESTHESIA (numbness and tingling), BACK PAIN (low back pain), PAIN (prickling sensation) and HEADACHE (cervogenic headaches). The patient was treated with GABAPENTIN at an unspecified dose and frequency. At the time of the report, PARAESTHESIA (numbness and tingling), NEURALGIA (nerve pain), BACK PAIN (low back pain), PAIN (prickling sensation), MYALGIA (muscle pain) and HEADACHE (cervogenic headaches) outcome was unknown.            No concomitant medications were reported.  Action taken with mRNA-1273 in response to the event was not applicable.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: fever since 12 weeks ago; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever since 12 weeks ago) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 016M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concurrent medical conditions included Diabetes. Concomitant products included ATENOLOL, PANTOPRAZOLE, FLUOXETINE HYDROCHLORIDE (PROZAC), AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) and INSULIN for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Jan-2021, the patient experienced PYREXIA (fever since 12 weeks ago). At the time of the report, PYREXIA (fever since 12 weeks ago) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications include diabetes medications. The patient did not receive treatment medications. Patient went to her endocrinologist and urgent care and they haven't been able to advise her on what to do.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.  However, additional information has been requested regarding the event that continued 12 weeks after the first dose of vaccine.
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Rash; itchiness; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash) and PRURITUS (itchiness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (Rash) and PRURITUS (itchiness). At the time of the report, RASH (Rash) and PRURITUS (itchiness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No treatment drugs were reported. No contact information provided. Transfer was not completed, call dropped.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Breast swelling
Clinical narrative: swelling in breast; This spontaneous case was reported by a consumer and describes the occurrence of BREAST SWELLING (swelling in breast) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced BREAST SWELLING (swelling in breast). At the time of the report, BREAST SWELLING (swelling in breast) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. The patient did not mention any treatment medications.  Very limited information regarding this event has been provided at this time.  Further information has been requested.; Sender's Comments: Very limited information regarding this event has been provided at this time.  Further information has been requested.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: redness under the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (redness under the injection site) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness under the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (redness under the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were not provided. No treatment medications were not provided.
Age: 72.0
Sex: U
Vaccine: COVID19
Symptoms: Swelling, Vaccination site pain
Clinical narrative: pain at the injection site; swelling; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain at the injection site) and SWELLING (swelling) in a 72-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Apr-2021, the patient experienced VACCINATION SITE PAIN (pain at the injection site) and SWELLING (swelling). At the time of the report, VACCINATION SITE PAIN (pain at the injection site) and SWELLING (swelling) outcome was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Pharyngitis streptococcal
Clinical narrative: Developed Strep throat; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PHARYNGITIS STREPTOCOCCAL (Developed Strep throat) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PHARYNGITIS STREPTOCOCCAL (Developed Strep throat). At the time of the report, PHARYNGITIS STREPTOCOCCAL (Developed Strep throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Diarrhoea, Nausea, Pyrexia, Rhinorrhoea
Clinical narrative: very upset stomach; ended up with diarrhea; nose was running; nauseated/feeling funky/stomach is still a little funky; low grade fever; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of ABDOMINAL DISCOMFORT (very upset stomach), DIARRHOEA (ended up with diarrhea), RHINORRHOEA (nose was running), NAUSEA (nauseated/feeling funky/stomach is still a little funky) and PYREXIA (low grade fever) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ONDANSETRON for Nausea, RIVAROXABAN (XARELTO), AMOXICILLIN TRIHYDRATE, CLARITHROMYCIN, ESOMEPRAZOLE MAGNESIUM (NEXIUM 1-2-3), DILTIAZEM HYDROCHLORIDE (CARTIA XT), CARVEDILOL, LISINOPRIL, GABAPENTIN and FAMOTIDINE for an unknown indication.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced ABDOMINAL DISCOMFORT (very upset stomach), DIARRHOEA (ended up with diarrhea), RHINORRHOEA (nose was running), NAUSEA (nauseated/feeling funky/stomach is still a little funky) and PYREXIA (low grade fever). At the time of the report, ABDOMINAL DISCOMFORT (very upset stomach), DIARRHOEA (ended up with diarrhea), RHINORRHOEA (nose was running), NAUSEA (nauseated/feeling funky/stomach is still a little funky) and PYREXIA (low grade fever) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Gait inability
Clinical narrative: had no energy; could barely crawl up the stairs; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (had no energy) and GAIT INABILITY (could barely crawl up the stairs) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (had no energy) and GAIT INABILITY (could barely crawl up the stairs). At the time of the report, ASTHENIA (had no energy) and GAIT INABILITY (could barely crawl up the stairs) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Asthenia, Diarrhoea, Fatigue
Clinical narrative: stomach cramps; diarrhea; no energy; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (stomach cramps), FATIGUE (fatigue), DIARRHOEA (diarrhea) and ASTHENIA (no energy) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL PAIN UPPER (stomach cramps), FATIGUE (fatigue), DIARRHOEA (diarrhea) and ASTHENIA (no energy). At the time of the report, ABDOMINAL PAIN UPPER (stomach cramps), FATIGUE (fatigue), DIARRHOEA (diarrhea) and ASTHENIA (no energy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Right arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Right arm was sore) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced PAIN IN EXTREMITY (Right arm was sore). At the time of the report, PAIN IN EXTREMITY (Right arm was sore) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medication was reported. No treatment medication was reported.   This case was linked to MOD-2021-085234 (Patient Link).
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Influenza like illness, Myalgia
Clinical narrative: Had flu like symptoms; headaches; chills; body aches.; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Had flu like symptoms), HEADACHE (headaches), CHILLS (chills) and MYALGIA (body aches.) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Had flu like symptoms), HEADACHE (headaches), CHILLS (chills) and MYALGIA (body aches.). At the time of the report, INFLUENZA LIKE ILLNESS (Had flu like symptoms), HEADACHE (headaches), CHILLS (chills) and MYALGIA (body aches.) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-085226 (Patient Link).
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Gait disturbance, Musculoskeletal stiffness
Clinical narrative: hadn't walked too much; shot made me feel like was having another stroke; stiff; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (stiff), GAIT DISTURBANCE (hadn't walked too much) and FEELING ABNORMAL (shot made me feel like was having another stroke) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0044B21A) for COVID-19 vaccination.     Concurrent medical conditions included Stroke. Concomitant products included PREGABALIN for Nerve pain, ATORVASTATIN CALCIUM, EZETIMIBE (STATIN EZ), AMITRIPTYLINE HYDROCHLORIDE (AMITRIPTYLENE) and DIAZEPAM for an unknown indication.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (stiff). On an unknown date, the patient experienced GAIT DISTURBANCE (hadn't walked too much) and FEELING ABNORMAL (shot made me feel like was having another stroke). At the time of the report, MUSCULOSKELETAL STIFFNESS (stiff), GAIT DISTURBANCE (hadn't walked too much) and FEELING ABNORMAL (shot made me feel like was having another stroke) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Added medical history stroke.Event added
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Missed second dose of Moderna vaccine due to having had ankle surgery; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed second dose of Moderna vaccine due to having had ankle surgery) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Ankle operation.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed second dose of Moderna vaccine due to having had ankle surgery). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Missed second dose of Moderna vaccine due to having had ankle surgery) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant Medication was provided. No treatment  was provided.
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Patient missed second dose of Moderna vaccine due to having had ankle surgery. Patient stated she would not be able to stand in line to get dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient missed second dose of Moderna vaccine due to having had ankle surgery. Patient stated she would not be able to stand in line to get dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Ankle operation.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient missed second dose of Moderna vaccine due to having had ankle surgery. Patient stated she would not be able to stand in line to get dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Patient missed second dose of Moderna vaccine due to having had ankle surgery. Patient stated she would not be able to stand in line to get dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No  concomitant medical  provided by the reporter. No treatment information provided by the reporter.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Cough, Myalgia, Pain in extremity
Clinical narrative: bodyache; Cough; His left arm is hurting; This morning, he started with chills; He started with fever of 99/fever went from 99 to 101 in the afternoon; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (bodyache), COUGH (Cough), PAIN IN EXTREMITY (His left arm is hurting), CHILLS (This morning, he started with chills) and PYREXIA (He started with fever of 99/fever went from 99 to 101 in the afternoon) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0046214) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included ATENOLOL for an unknown indication.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced PYREXIA (He started with fever of 99/fever went from 99 to 101 in the afternoon). On 22-Apr-2021, the patient experienced MYALGIA (bodyache), COUGH (Cough), PAIN IN EXTREMITY (His left arm is hurting) and CHILLS (This morning, he started with chills). At the time of the report, MYALGIA (bodyache), COUGH (Cough), PAIN IN EXTREMITY (His left arm is hurting), CHILLS (This morning, he started with chills) and PYREXIA (He started with fever of 99/fever went from 99 to 101 in the afternoon) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Apr-2021, Body temperature: 101 (High) 101 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications also  included Ulcer medication and allergy medicine.  No treatment medications were provided by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 03-Aug-2021: Follow up received and AE outcome was updated from Unknown to Recovered. Significant FU.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: bodyache; Cough; His left arm is hurting; This morning, he started with chills; He started with fever of 99/fever went from 99 to 101 in the afternoon; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (bodyache), COUGH (Cough), PAIN IN EXTREMITY (His left arm is hurting), CHILLS (This morning, he started with chills) and PYREXIA (He started with fever of 99/fever went from 99 to 101 in the afternoon) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0046214) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included ATENOLOL for an unknown indication.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced PYREXIA (He started with fever of 99/fever went from 99 to 101 in the afternoon). On 22-Apr-2021, the patient experienced MYALGIA (bodyache), COUGH (Cough), PAIN IN EXTREMITY (His left arm is hurting) and CHILLS (This morning, he started with chills). At the time of the report, MYALGIA (bodyache), COUGH (Cough), PAIN IN EXTREMITY (His left arm is hurting), CHILLS (This morning, he started with chills) and PYREXIA (He started with fever of 99/fever went from 99 to 101 in the afternoon) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Apr-2021, Body temperature: 101 (High) 101 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications also  included Ulcer medication and allergy medicine.  No treatment medications were provided by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 03-Aug-2021: Follow up received and AE outcome was updated from Unknown to Recovered. Significant FU.
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headaches were more intense; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headaches were more intense) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Headache (Patient reported that he usually had headaches).    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headaches were more intense). At the time of the report, HEADACHE (headaches were more intense) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Feeling abnormal, Myalgia, Pyrexia
Clinical narrative: general body aches, more in legs than anywhere else; described it as feeling like 'getting hit by truck'; fever of 99.2; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (general body aches, more in legs than anywhere else), FEELING ABNORMAL (described it as feeling like 'getting hit by truck') and PYREXIA (fever of 99.2) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, the patient experienced PAIN (general body aches, more in legs than anywhere else), FEELING ABNORMAL (described it as feeling like 'getting hit by truck') and PYREXIA (fever of 99.2). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of 1000 mg. At the time of the report, PAIN (general body aches, more in legs than anywhere else), FEELING ABNORMAL (described it as feeling like 'getting hit by truck') and PYREXIA (fever of 99.2) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: fever (High) Fever.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Lab data includes Body Temperature 99.2 was added
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pyrexia, Taste disorder, Tenderness
Clinical narrative: fever; tenderness at the injection site; weird taste in the mouth; headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), TENDERNESS (tenderness at the injection site), TASTE DISORDER (weird taste in the mouth) and HEADACHE (headache) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced PYREXIA (fever), TENDERNESS (tenderness at the injection site), TASTE DISORDER (weird taste in the mouth) and HEADACHE (headache). At the time of the report, PYREXIA (fever), TENDERNESS (tenderness at the injection site), TASTE DISORDER (weird taste in the mouth) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications provided. Treatment included Tylenol and Aleve   This case was linked to US-MODERNATX, INC.-MOD-2021-085590 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-085590:Case for husband
Age: 61.0
Sex: U
Vaccine: COVID19
Symptoms: Peripheral swelling, Pruritus, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching on fingers, arms, stomach, neck, and knees), PERIPHERAL SWELLING (fingers seem swollen) and PYREXIA (fever) in a 61-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007B21A and 0486B21A) for COVID-19 vaccination. No Medical History information was reported. Concomitant medication was not provided. On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced PRURITUS (itching on fingers, arms, stomach, neck, and knees) and PERIPHERAL SWELLING (fingers seem swollen). On 21-Apr-2021, the patient experienced PYREXIA (fever). On 21-Apr-2021, PYREXIA (fever) had resolved. At the time of the report, PRURITUS (itching on fingers, arms, stomach, neck, and knees) and PERIPHERAL SWELLING (fingers seem swollen) outcome was unknown. Not Provided. Concomitant medication was not provided. Treatment information was not provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Suspected COVID-19
Clinical narrative: Covid like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of SUSPECTED COVID-19 (Covid like symptoms) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, the patient experienced SUSPECTED COVID-19 (Covid like symptoms). The patient was treated with CHLORPHENAMINE MALEATE, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (THERAFLU [CHLORPHENAMINE MALEATE;PARACETAMOL;PSEUDOEPHEDRINE HYDROCHLORIDE]) at an unspecified dose and frequency; ZINC at an unspecified dose and frequency; VITAMIN B COMPLEX at an unspecified dose and frequency and VITAMIN C [ASCORBIC ACID] at an unspecified dose and frequency. At the time of the report, SUSPECTED COVID-19 (Covid like symptoms) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Apr-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications included Blood pressure medication.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Cough, Dyspnoea, Tremor
Clinical narrative: shaking; joint pain; couldn't catch his breath; cough; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DYSPNOEA (couldn't catch his breath), COUGH (cough), TREMOR (shaking) and ARTHRALGIA (joint pain) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced DYSPNOEA (couldn't catch his breath), COUGH (cough) and ARTHRALGIA (joint pain). On 22-Apr-2021, the patient experienced TREMOR (shaking). At the time of the report, DYSPNOEA (couldn't catch his breath), COUGH (cough), TREMOR (shaking) and ARTHRALGIA (joint pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was included steroids, anti-inflammatory and morphine.  No Concomitant products was reported.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Hypersensitivity, Pain, Pruritus
Clinical narrative: red, itchy and painful allergy known as "culebrilla" in the US; red, itchy and painful allergy known as "culebrilla" in the US; red, itchy and painful allergy known as "culebrilla" in the US; red, itchy and painful allergy known as "culebrilla" ; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (red, itchy and painful allergy known as "culebrilla" in the US), ERYTHEMA (red, itchy and painful allergy known as "culebrilla" ), PRURITUS (red, itchy and painful allergy known as "culebrilla" ) and HYPERSENSITIVITY in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     Concomitant products included VITAMINS NOS for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced PAIN (red, itchy and painful allergy known as "culebrilla" ), ERYTHEMA (red, itchy and painful allergy known as "culebrilla" in the US), PRURITUS (red, itchy and painful allergy known as "culebrilla" ) and HYPERSENSITIVITY (red, itchy and painful allergy known as "culebrilla"). The patient was treated with ACYCLOVIR [ACICLOVIR] at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, PAIN (red, itchy and painful allergy known as "culebrilla"), ERYTHEMA (red, itchy and painful allergy known as "culebrilla" ), PRURITUS (red, itchy and painful allergy known as "culebrilla" ) and HYPERSENSITIVITY (red, itchy and painful allergy known as "culebrilla" in the US) outcome was unknown. Not Provided, The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Injection site pain, Insomnia
Clinical narrative: Insomnia; Injection site pain; Joint pain in her fingers and hands; Muscle pain in her fingers and hands; Fatigue; Chills; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Insomnia), INJECTION SITE PAIN (Injection site pain), ARTHRALGIA (Joint pain in her fingers and hands), MYALGIA (Muscle pain in her fingers and hands) and FATIGUE (Fatigue) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL), SERTRALINE and CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for an unknown indication.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced INSOMNIA (Insomnia), INJECTION SITE PAIN (Injection site pain), ARTHRALGIA (Joint pain in her fingers and hands), MYALGIA (Muscle pain in her fingers and hands), FATIGUE (Fatigue), CHILLS (Chills) and NAUSEA (Nausea). At the time of the report, INSOMNIA (Insomnia), INJECTION SITE PAIN (Injection site pain), ARTHRALGIA (Joint pain in her fingers and hands), MYALGIA (Muscle pain in her fingers and hands), FATIGUE (Fatigue), CHILLS (Chills) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatments were not provided.   Reporter did not allow further contact
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea
Clinical narrative: Insomnia; Injection site pain; Joint pain in her fingers and hands; Muscle pain in her fingers and hands; Fatigue; Chills; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Insomnia), INJECTION SITE PAIN (Injection site pain), ARTHRALGIA (Joint pain in her fingers and hands), MYALGIA (Muscle pain in her fingers and hands) and FATIGUE (Fatigue) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL), SERTRALINE and CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for an unknown indication.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced INSOMNIA (Insomnia), INJECTION SITE PAIN (Injection site pain), ARTHRALGIA (Joint pain in her fingers and hands), MYALGIA (Muscle pain in her fingers and hands), FATIGUE (Fatigue), CHILLS (Chills) and NAUSEA (Nausea). At the time of the report, INSOMNIA (Insomnia), INJECTION SITE PAIN (Injection site pain), ARTHRALGIA (Joint pain in her fingers and hands), MYALGIA (Muscle pain in her fingers and hands), FATIGUE (Fatigue), CHILLS (Chills) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatments were not provided.   Reporter did not allow further contact
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Pain in extremity
Clinical narrative: painful right shoulder at injection site; arm hurts, little pain on the R arm of injection; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm hurts, little pain on the R arm of injection) and ARTHRALGIA (painful right shoulder at injection site) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007N204) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP) and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm hurts, little pain on the R arm of injection). On an unknown date, the patient experienced ARTHRALGIA (painful right shoulder at injection site). At the time of the report, PAIN IN EXTREMITY (arm hurts, little pain on the R arm of injection) had not resolved and ARTHRALGIA (painful right shoulder at injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication was reported. No treatment medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Additional info received  added the event "arthralgia" as per recent followup
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Vaccination site warmth
Clinical narrative: Injection site it was warm to the touch; Pain up to the shoulder; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Injection site it was warm to the touch) and ARTHRALGIA (Pain up to the shoulder) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Injection site it was warm to the touch) and ARTHRALGIA (Pain up to the shoulder). At the time of the report, VACCINATION SITE WARMTH (Injection site it was warm to the touch) and ARTHRALGIA (Pain up to the shoulder) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication were reporter No treatment information were reported   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Vision blurred, Wrong product administered
Clinical narrative: 2nd Vaccination was not Moderna brand; Blurry vision; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (Blurry vision) and WRONG PRODUCT ADMINISTERED (2nd Vaccination was not Moderna brand) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     The patient's past medical history included Atrial fibrillation.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced VISION BLURRED (Blurry vision). On 03-Mar-2021, the patient experienced WRONG PRODUCT ADMINISTERED (2nd Vaccination was not Moderna brand). At the time of the report, VISION BLURRED (Blurry vision) and WRONG PRODUCT ADMINISTERED (2nd Vaccination was not Moderna brand) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       MD told to patient to pre-medicate with Benadryl and Advil prior to 2nd Vaccination.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Rhinorrhoea, Sneezing
Clinical narrative: runny nose; sneezing; Testing Positive for Covid.; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Testing Positive for Covid.), RHINORRHOEA (runny nose) and SNEEZING (sneezing) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE, CITALOPRAM and TRAZODONE for an unknown indication.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced COVID-19 (Testing Positive for Covid.). On an unknown date, the patient experienced RHINORRHOEA (runny nose) and SNEEZING (sneezing). At the time of the report, COVID-19 (Testing Positive for Covid.), RHINORRHOEA (runny nose) and SNEEZING (sneezing) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Upon internal review on 04-Aug-2021, age units was updated to years.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Syringe issue
Clinical narrative: she reported that the syringe broke in her arm and got medicine on arm; muscle soreness; This spontaneous case was reported by a consumer and describes the occurrence of SYRINGE ISSUE (she reported that the syringe broke in her arm and got medicine on arm) and MYALGIA (muscle soreness) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, the patient experienced SYRINGE ISSUE (she reported that the syringe broke in her arm and got medicine on arm) and MYALGIA (muscle soreness). On 21-Apr-2021, MYALGIA (muscle soreness) had resolved. At the time of the report, SYRINGE ISSUE (she reported that the syringe broke in her arm and got medicine on arm) outcome was unknown.            No concomitant medication were reported.  No treatment medication was reported.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Influenza like illness, Myalgia
Clinical narrative: shaky and it made him nervous; shaky; flu like symptoms; muscle pain; joint pain; chills; nausea; headaches; This spontaneous case was reported by a consumer and describes the occurrence of NERVOUSNESS (shaky and it made him nervous), TREMOR (shaky), INFLUENZA LIKE ILLNESS (flu like symptoms), MYALGIA (muscle pain) and ARTHRALGIA (joint pain) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, the patient experienced NERVOUSNESS (shaky and it made him nervous), TREMOR (shaky), INFLUENZA LIKE ILLNESS (flu like symptoms), MYALGIA (muscle pain), ARTHRALGIA (joint pain), CHILLS (chills), NAUSEA (nausea) and HEADACHE (headaches). At the time of the report, NERVOUSNESS (shaky and it made him nervous), TREMOR (shaky), INFLUENZA LIKE ILLNESS (flu like symptoms), MYALGIA (muscle pain), ARTHRALGIA (joint pain), CHILLS (chills), NAUSEA (nausea) and HEADACHE (headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were provided  Treatment medication was not provided
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Nervousness, Tremor
Clinical narrative: shaky and it made him nervous; shaky; flu like symptoms; muscle pain; joint pain; chills; nausea; headaches; This spontaneous case was reported by a consumer and describes the occurrence of NERVOUSNESS (shaky and it made him nervous), TREMOR (shaky), INFLUENZA LIKE ILLNESS (flu like symptoms), MYALGIA (muscle pain) and ARTHRALGIA (joint pain) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, the patient experienced NERVOUSNESS (shaky and it made him nervous), TREMOR (shaky), INFLUENZA LIKE ILLNESS (flu like symptoms), MYALGIA (muscle pain), ARTHRALGIA (joint pain), CHILLS (chills), NAUSEA (nausea) and HEADACHE (headaches). At the time of the report, NERVOUSNESS (shaky and it made him nervous), TREMOR (shaky), INFLUENZA LIKE ILLNESS (flu like symptoms), MYALGIA (muscle pain), ARTHRALGIA (joint pain), CHILLS (chills), NAUSEA (nausea) and HEADACHE (headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were provided  Treatment medication was not provided
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Pain
Clinical narrative: Diarrhea; body aches; headaches; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), PAIN (body aches) and HEADACHE (headaches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Diarrhea), PAIN (body aches) and HEADACHE (headaches). At the time of the report, DIARRHOEA (Diarrhea), PAIN (body aches) and HEADACHE (headaches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported Treatment information was not provided
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Hypersensitivity, Vaccination site erythema
Clinical narrative: allergic reaction; hot redness of the size of an orange; five days after receiving her first dose of the Moderna vaccine she experienced got hot, but didn't swell, lasted for 10 days; This spontaneous case was reported by a patient and describes the occurrence of HYPERSENSITIVITY (allergic reaction), VACCINATION SITE ERYTHEMA (hot redness of the size of an orange) and FEELING HOT (five days after receiving her first dose of the Moderna vaccine she experienced got hot, but didn't swell, lasted for 10 days) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  The patient's past medical history included No adverse event. Concomitant products included ERGOCALCIFEROL, RETINOL PALMITATE (VITAMINS A & D) for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, the patient experienced FEELING HOT (five days after receiving her first dose of the Moderna vaccine she experienced got hot, but didn't swell, lasted for 10 days). On an unknown date, the patient experienced HYPERSENSITIVITY (allergic reaction) and VACCINATION SITE ERYTHEMA (hot redness of the size of an orange). At the time of the report, HYPERSENSITIVITY (allergic reaction) and VACCINATION SITE ERYTHEMA (hot redness of the size of an orange) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-085334 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Non-Significant F/U AE Info Updates.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-085334:2 dose